With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.

Swiss startup Oxyle announced a $16m funding round to scale its breakthrough solution to destroy, not just relocate, PFAS from wastewater. This builds on its $3M pre-seed round in 2022, growing ...

Legacy financial institutions, such as Germany’s oldest bank, Bankhaus Metzler, and global asset manager BlackRock, are integrating solutions from Swiss fintech startups to boost efficiency. Meanwhile ...

The Mission for Essential Drugs and Supplies (MEDS) in Kenya and CHAN Medi-Pharm in Nigeria, as well as Ecumenical Pharmaceutical Network (EPN) have joined forced with Swiss startup Axmed to improve ...

Yokoy, the leading spend management platform, has been acquired by TravelPerk, a business travel platform based in Barcelona. In parallel, TravelPerk announced the closing of a financing round in ...

Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics. By combining the safety of soft robotics with industrial ...

Several Swiss start-ups have secured the necessary funds to conquer global markets.

Zurich-based ACP Advanced Circuit Pursuit AG, recognized for its robust IP portfolio and expertise in RF CMOS technology starts a new era as part of Paris-based Sequans Communications SA, a leading ...

Major companies in the automotive, energy and agriculture sector are relying on Swiss startups to reach their CO2 emissions targets, achieve efficiency in electricity network monitoring and enable ...

Five Swiss startups are among the nine startups selected to join the second edition of the Digital Health Centre Bülach and Tenity. During four-months, participants will receive tailored support and ...

Startups supported by Venture Kick have made remarkable achievements, with 66 Venture Kick alumni recognized among the TOP 100 Swiss Startups 2024. And despite a difficult fundraising environment, the ...

AB2 Bio has entered into an option and licensing agreement with Nippon Shinyaku Co. Ltd., a leading Japanese pharmaceutical company with extensive experience in marketing rare disease therapeutics in ...